Table 1.
Signaling pathway | Positive regulationa | Negative regulationa | Primary cellular effectsb | Secondary cellular effectsb |
---|---|---|---|---|
| ||||
ERK 1/2 | PDGF, CTGF, PAR-2, ROS, Angiotensin II | ATRA | PMF proliferation | Collagen expression |
JNK | PDGF, PAR-2, ROS | ATRA | PMF proliferation | Collagen expression |
p38 | PDGF, PAR-2, ROS | ATRA | PMF proliferation | Collagen expression |
RhoA/ROCK1 | PDGF | NA | Potentiate PDGF-induced proliferation and migration | Collagen and SMA expression |
YAP1 | Matricellular stress | ATRA | Potentiate TGF-β1 and PDGF signaling | NA |
SMAD2/3 | TGF-β1, Activin A, matricellular stress | BMP2, SMAD1/5/8, STAT1 | ECM deposition | Expression of PDGFR, and CTGF |
Positive and negative regulators refer to factors that activate and suppress a given signaling pathway
Primary and secondary cellular effects refer to the results of the activation of that pathway in PMFs